If you’ve ever been hit with a case of the hiccups at the worst possible moment, you’re not alone, and thanks to HiccAway, millions found relief in an unexpected place: a medical-grade straw. But just how successful has this product become since its Shark Tank debut? And more importantly, what is HiccAway’s net worth in 2025?
Founded by a neurointensivist and backed by a billionaire Shark, HiccAway became a fascinating case study in innovation, persistence, and market traction. Here’s the full breakdown.
Who’s Behind HiccAway? Meet the Founders
HiccAway was co-founded by Dr. Ali Seifi, Amanda Azarpour, and Victor Feldberg. Dr. Seifi, a board-certified neurointensivist, developed the device based on his deep understanding of the human nervous system.
After seeing numerous patients suffering from persistent hiccups in hospital settings, he knew there had to be a better solution than the old-school tricks.
“I wanted to create something simple yet scientifically backed that anyone could use,” said Dr. Seifi in an interview with Shark Tank Global.
Victor Feldberg brought the business acumen, while Amanda Azarpour focused on marketing and outreach. The trio worked tirelessly to bring their product to life, eventually publishing clinical results that demonstrated a 90% success rate for hiccup relief.
As of 2025, Dr. Ali Seifi’s estimated net worth is between $1.5 million to $2 million, largely driven by his role in developing HiccAway and ongoing medical research ventures.
Co-founders Amanda Azarpour and Victor Feldberg are estimated to be worth $500,000 to $1 million each, thanks to their equity in the business and growth since the Shark Tank deal.
The Shark Tank Pitch: High Stakes in the Tank
In Season 13, Episode 1 of Shark Tank, the trio stepped into the Tank asking for $250,000 in exchange for 10% equity. The Sharks were intrigued.
Mark Cuban, who admitted to struggling with chronic hiccups, was visibly impressed. “This is genius. I’ve literally taken muscle relaxers because of hiccups,” he shared during the pitch.
Dr. Seifi explained how the device uses specific pressure dynamics to stimulate the phrenic and vagus nerves, effectively resetting the diaphragm and eliminating the hiccup reflex. The science impressed the panel, but it was the testimonials that sealed the deal.
In the end, Mark Cuban offered $250,000 for a 20% stake, and the founders accepted. The deal was praised as both strategic and emotional, given Cuban’s personal history with the problem.
HiccAway Pitch on Shark Tank (Quick Info Card).
| Company name | HiccAway |
| Product | Hiccup treatment straw |
| Episode | Season 13 Episode 12 |
| Founders | Dr. Ali Seifi, Amanda Azarpour, Victor Feldberg |
| Asked for | $250,000 for 10% equity |
| Final deal | $250,000 for 20% equity |
| Shark | Mark Cuban |
| Location | Longmont, Colorado, United States |
Did the Sharks’ Investment Pay Off? Inside HiccAway’s Post-Tank Boom
Following their Shark Tank appearance, HiccAway experienced a dramatic spike in sales. The device quickly sold out on Amazon and became a top trending item in health and wellness.
The product also secured shelf space in major pharmacy chains and expanded internationally through e-commerce platforms.
“We went from just a few thousand units sold to over 500,000 units globally,” said Amanda Azarpour in a 2025 update. “The Shark Tank exposure was just the beginning. Mark Cuban’s mentorship gave us the roadmap for scaling.”
Estimates place HiccAway’s 2025 net worth around $3.2 million, based on revenue, IP value, and remaining inventory.
Was This the Sharks’ Best Deal Yet? Breaking Down the Profits
Mark Cuban’s $250,000 investment for a 20% stake means his equity is now worth approximately $640,000 based on the current valuation. That’s a 2.56x return in under three years.
While not quite as explosive as investments like Ring or Bombas, HiccAway represents a strategic win in the medical device niche, one with global health relevance.
Cuban has often emphasized the value of solving “real-world” problems, and HiccAway aligns perfectly with that vision.
What Happened After Shark Tank? New Growth & Reviews
Post-show, HiccAway expanded into over 15 countries and earned FDA Class 1 designation, a major milestone for a consumer health product. The brand also redesigned its packaging for retail and launched a new kid-friendly version.
However, not all feedback was glowing. Some customers noted that the product doesn’t work for all types of hiccups or requires repeated tries. On Amazon, it holds an average 3.9-star rating from over 3,000 reviews.
“It worked for me, but not for my wife,” one reviewer noted. Others mentioned durability concerns with the straw’s valve.
Despite these issues, the majority of users still reported fast and effective results.
Business Challenges & Strategy
Scaling a medical device into a global consumer product comes with regulatory, logistic, and consumer education hurdles.
“The biggest challenge was convincing people this wasn’t just another gimmick,” said Victor Feldberg. “We leaned heavily on science, press exposure, and doctor endorsements to build trust.”
By maintaining low production costs and leveraging direct-to-consumer sales, HiccAway avoided the common pitfall of high burn rates.
Their long-term strategy focused on product line expansion and global distribution.
How Much Was HiccAway Bought For? Is It Closed or Rebranded?
As of 2025, HiccAway has not been sold and continues to operate under its original name. The official website is active, and the product remains available on Amazon and through international retailers.
There are no indications that the company is closed or rebranded. Instead, it appears to be growing steadily, albeit outside the media spotlight.
Mark Cuban’s Other Investments
HiccAway fits well within Cuban’s investment strategy of practical, health-focused products. He has also invested in:
- ThroatScope (diagnostic device)
- BeatBox Beverages
- Dude Wipes
- Ready, Set, Food!
His portfolio reflects a pattern, solving everyday problems with simple, scalable solutions.
RELATED: The Best Shark Tank Products
Final Thoughts: The Wisdom Behind HiccAway’s Journey
While HiccAway didn’t become a $100 million juggernaut like Bombas, it stands as a compelling example of niche success. The company turned a quirky human problem into a real business, one rooted in science and simplicity.
Its path underscores an often overlooked truth, you don’t need a massive market to make a meaningful impact. You just need to solve a persistent pain point, tell a compelling story, and execute with discipline.
As Dr. Seifi puts it, “Sometimes, the simplest solutions are the most powerful.”
TL;DR
HiccAway net worth in 2024 is $3.2 million. The company is still running, with steady growth after its Shark Tank deal with Mark Cuban.
